Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma

被引:24
作者
Sun, Ping-Li [1 ,2 ]
Jin, Yan [1 ]
Kim, Hyojin [1 ]
Seo, An Na [1 ]
Jheon, Sanghoon [2 ]
Lee, Choon-Taek [3 ]
Chung, Jin-Haeng [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam 463707, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Songnam 463707, Gyeonggi Do, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Songnam 463707, Gyeonggi Do, South Korea
关键词
Non-small cell lung cancer; Prognosis; Apoptosis; Survivin; INHIBITOR-INDUCED APOPTOSIS; CANCER; GENE; METAANALYSIS; SUBTYPES;
D O I
10.1007/s00428-013-1462-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Survivin is a member of the inhibitors of apoptosis and frequently overexpressed in various cancer cells. Overexpression of survivin in lung cancer cells attenuates antitumor effect of tyrosine kinase inhibitors. However, data from the previous studies on the clinicopathologic implication of survivin in non-small-cell lung carcinoma (NSCLC) are inconsistent. We investigated the expression of survivin in 373 cases of surgically resected NSCLC. Correlations between the expression of survivin and clinicopathologic, molecular features and prognostic significance were analyzed. In adenocarcinoma, the increased expression of survivin was associated with the presence of vascular invasion, lymph node metastasis, and tumor recurrences, but we didn't find any correlation with survivin expression and clinicopathological parameters in squamous cell carcinoma. Patients with high survivin expression had significantly shorter disease-free survival (DFS; 42.2 vs. 58.8 months; p=0.001) and shorter overall survival (OS; 60.8 vs. 71.5 months; p=0.009) than those with low survivin expression group in adenocarcinoma. In squamous cell carcinoma, the expression of survivin was not associated with prognosis of the patients (DFS; 48.9 vs. 48.7 months; p=0.837, OS; 61.0 vs. 62.4 months; p=0.771). Multivariate analysis confirmed that survivin was an independent poor prognostic factor in adenocarcinoma (DFS: hazard ratio (HR), 1.687; 95 % confidence interval (CI), 1.123-2.532; p=0.012; OS: HR, 1.965; 95 % CI, 1.108-3.486; p=0.021). There was no statistically significant difference in the expression of survivin among different molecular subgroups (p>0.05). Our results suggest that survivin is an independent negative prognostic factor in adenocarcinoma, but not in squamous cell carcinoma. The different prognostic roles played by survivin in adenocarcinoma and squamous cell carcinoma highlights the biological differences between these two histologic types.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 29 条
[1]   Survivin expression in pre-invasive lesions and non-small cell lung carcinoma [J].
Akyurek, Nalan ;
Memis, Leyla ;
Ekinci, Ozgur ;
Kokturk, Nurdan ;
Ozturk, Can .
VIRCHOWS ARCHIV, 2006, 449 (02) :164-170
[2]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[3]   Correlation between survivin expression and prognosis in non-small cell lung cancer [J].
Atikcan, Sukran ;
Unsal, Ebru ;
Demirag, Funda ;
Koksal, Deniz ;
Yilmaz, Aydin .
RESPIRATORY MEDICINE, 2006, 100 (12) :2220-2226
[4]   Treat cancers by targeting survivin: Just a dream or future reality? [J].
Coumar, Mohane Selvaraj ;
Tsai, Fang-Ying ;
Kanwar, Jagat Rakesh ;
Sarvagalla, Sailu ;
Cheung, Chun Hei Antonio .
CANCER TREATMENT REVIEWS, 2013, 39 (07) :802-811
[5]   Survivin gene expression in early-stage non-small cell lung cancer [J].
Falleni, M ;
Pellegrini, C ;
Marchetti, A ;
Oprandi, B ;
Buttitta, F ;
Barassi, F ;
Santambrogio, L ;
Coggi, G ;
Bosari, S .
JOURNAL OF PATHOLOGY, 2003, 200 (05) :620-626
[6]   The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures [J].
Fan, Jiang ;
Wang, Lei ;
Jiang, Ge-Ning ;
He, Wen-Xin ;
Ding, Jia-An .
LUNG CANCER, 2008, 61 (01) :91-96
[7]   Non-small-cell lung cancer [J].
Goldstraw, Peter ;
Ball, David ;
Jett, James R. ;
Le Chevalier, Thierry ;
Lim, Eric ;
Nicholson, Andrew G. ;
Shepherd, Frances A. .
LANCET, 2011, 378 (9804) :1727-1740
[8]   Molecular origins of cancer: Lung cancer [J].
Herbst, Roy S. ;
Heymach, John V. ;
Lippman, Scott M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1367-1380
[9]   Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients [J].
Hinnis, A. R. ;
Luckett, J. C. A. ;
Walker, R. A. .
BRITISH JOURNAL OF CANCER, 2007, 96 (04) :639-645
[10]   Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies [J].
Huang, Li-nian ;
Wang, Dong-sheng ;
Chen, Yu-qing ;
Zhao, Cheng-ling ;
Gong, Bei-lei ;
Jiang, An-bang ;
Jia, Wei ;
Hu, Feng-dan .
MOLECULAR BIOLOGY REPORTS, 2013, 40 (02) :917-924